{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T16:38:26Z","timestamp":1740155906976,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,2,4]],"date-time":"2016-02-04T00:00:00Z","timestamp":1454544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/nrrheum.2016.9","type":"journal-article","created":{"date-parts":[[2016,2,4]],"date-time":"2016-02-04T05:41:30Z","timestamp":1454564490000},"page":"138-139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nucleosomes and systemic sclerosis"],"prefix":"10.1038","volume":"12","author":[{"given":"Steven","family":"O'Reilly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob M.","family":"van Laar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,4]]},"reference":[{"key":"BFnrrheum20169_CR1","doi-asserted-by":"publisher","unstructured":"Yoshizaki, A.  et al. Nucleosome in patients with systemic sclerosis: possible association with immunological abnormalities via abnormal activation of T and B cells. Ann. Rheum. Dis. \n                    http:\/\/dx.doi.org\/10.1136\/annrheumdis-2015-207405\n                    \n                   (2015).","DOI":"10.1136\/annrheumdis-2015-207405"},{"key":"BFnrrheum20169_CR2","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1002\/art.1780401217","volume":"40","author":"Z Amoura","year":"1997","unstructured":"Amoura, Z.  et al. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus. Correlation with serum antinucleosome antibody titers and absence of clear association with disease activity. Arthritis Rheum. 40, 2217\u20132225 (1997).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum20169_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/sji.12335","volume":"82","author":"M Magna","year":"2015","unstructured":"Magna, M. & Pisetsky, D. S. The role of cell death in the pathogenesis of SLE: is pyroptosis the missing link? Scand. J. Immunol. 82, 218\u2013224 (2015).","journal-title":"Scand. J. Immunol."},{"key":"BFnrrheum20169_CR4","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/35047123","volume":"408","author":"H Hemmi","year":"2000","unstructured":"Hemmi, H.  et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740\u2013745 (2000).","journal-title":"Nature"},{"key":"BFnrrheum20169_CR5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/exd.12673","volume":"24","author":"M Ciechomska","year":"2015","unstructured":"Ciechomska, M., van Laar, J. & O'Reilly, S. Current frontiers in systemic sclerosis pathogenesis. Exp. Dermatol. 24, 401\u2013406 (2015).","journal-title":"Exp. Dermatol."},{"key":"BFnrrheum20169_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00281-015-0503-7","volume":"37","author":"N Fullard","year":"2015","unstructured":"Fullard, N. & O'Reilly, S. Role of innate immune system in systemic sclerosis. Semin. Immunopathol. 37, 511\u2013517 (2015).","journal-title":"Semin. Immunopathol."},{"key":"BFnrrheum20169_CR7","doi-asserted-by":"publisher","first-page":"9952","DOI":"10.1074\/jbc.M113.545822","volume":"289","author":"S O'Reilly","year":"2014","unstructured":"O'Reilly, S., Ciechomska, M., Cant, R. & van Laar, J. M. Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-\u03b2 (TGF-\u03b2) signaling promoting SMAD3 activation and fibrosis via Gremlin protein. J. Biol. Chem. 289, 9952\u20139960 (2014).","journal-title":"J. Biol. Chem."},{"key":"BFnrrheum20169_CR8","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.semarthrit.2014.09.002","volume":"44","author":"SL Bosello","year":"2015","unstructured":"Bosello, S.L.  et al. Long term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis. Semin. Arthritis Rheum. 44, 428\u2013436 (2015).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrrheum20169_CR9","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1136\/annrheumdis-2012-201958","volume":"72","author":"M Ciechomska","year":"2013","unstructured":"Ciechomska, M.  et al. Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors. Ann. Rheum. Dis. 72, 1382\u20131389 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum20169_CR10","unstructured":"Balak, D.M.W.  et al. \n                    http:\/\/www.iderapharma.com\/wp-content\/uploads\/2015\/11\/imo-8400_psoriasis_aad_poster-final.pdf\n                    \n                   (2015)."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2016.9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2016.9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2016.9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:40:14Z","timestamp":1684471214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2016.9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,4]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFnrrheum20169"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2016.9","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"type":"print","value":"1759-4790"},{"type":"electronic","value":"1759-4804"}],"subject":[],"published":{"date-parts":[[2016,2,4]]},"assertion":[{"value":"4 February 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}